Tardive Dyskinesia Drugs Market Expected to stay High in North America during 2021-2027

Tardive dyskinesia may be a rare involuntary, often mute, motor neural disease caused by the excessive use of dopamine antagonist drugs that are usually prescribed to treat some psychiatric or gastrointestinal disorders. future use of such drugs can produce severe biochemical changes within the brain’s reward system, the a part of the brain which is involved in coordinating behavior with the actions of the body. the most causes that a number of those that take such drugs might acquire dyskinesia is unknown, but the most reasons that others don’t remains unknown.

The PDF for the study can be requested using the following link:

Market Dynamics

High prevalence of neurological diseases is predicted to propel growth of the dyskinesia drugs market. as an example , consistent with the planet Health Organization (WHO), the share of total disability-adjusted life years (DALYs) of epilepsy is predicted to account for 0.5% while of cerebrovascular diseases for 3.6%. Moreover, percentage of total DALYs of cerebrovascular disease is projected to succeed in 3.9%, while that of epilepsy is predicted to stay more or less constant by 2030. Moreover, high prevalence of dyskinesia is additionally expected to assist in growth of the market. the typical prevalence of dyskinesia is estimated to be a minimum of 20% of all patients who were treated with first-generation neuroleptics.

Increasing geriatric population is predicted to supply lucrative growth opportunities for players within the dyskinesia drugs market. as an example , consistent with the U.S. Bureau of the Census , the U.S. geriatric population is predicted to succeed in 77 million by 2034. Moreover, increasing sales of dyskinesia drugs is additionally expected to assist in growth of the market. as an example , in January 2021, Neurocrine Biosciences, Inc. reported that full-year 2020 total INGREZZA (INGREZZA may be a selective vesicular monoamine transporter 2 inhibitor indicated for the treatment of adults with tardive dyskinesia) prescriptions grew 32% to approximately 175,700 versus 2019 total prescriptions of roughly 132,700.

Competitive Analysis

Major players operating within the dyskinesia drugs market include, Valeant Pharmaceuticals, Neurocrine Biosciences, and Teva Pharmaceutical Industries.

Major players operating within the dyskinesia drugs market are focused on adopting various strategies to reinforce their market share. as an example , in September 2020, Neurocrine Biosciences, Inc. announced to present new data as a part of 30 abstracts accepted from its movement disorder programs for dyskinesia and paralysis agitans at the virtual scientific meetings, 2020 Psych Congress and therefore the MDS Virtual Congress 2020.

“Limited Time Offer”

We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027


About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformation growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Related Articles

Back to top button